Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy

PURPOSE: The prognosis of patients with advanced pancreatic ductal adenocarcinoma (PDAC) remains dismal. New cytotoxic agents such as nab-paclitaxel and liposomal irinotecan (nal-Iri) have extended the armamentarium of therapeutic options in the last years. Nowadays, sequential therapeutic strategie...

Descripción completa

Detalles Bibliográficos
Autores principales: Markus, M., Abendroth, A., Noureddine, R., Paul, A., Breitenbuecher, S., Virchow, I., Schmid, K. W., Markus, P., Schumacher, B., Wiesweg, M., Wendling, J., Mende, B., Siveke, J. T., Schuler, M., Kasper, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817578/
https://www.ncbi.nlm.nih.gov/pubmed/32839836
http://dx.doi.org/10.1007/s00432-020-03361-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817578/
https://www.ncbi.nlm.nih.gov/pubmed/32839836
http://dx.doi.org/10.1007/s00432-020-03361-0

Ejemplares similares